The global head and neck squamous cell carcinoma market is set for steady growth, driven by advancements in treatment options, increasing awareness of early cancer detection, and rising demand for ...

Approval based on results of landmark Phase 3 C-POST trial that show Libtayo is first immunotherapy to significantly improve disease-free ...

Squamous cell vulvar cancer is the most common type of vulvar cancer. It’s often diagnosed in the early stages when it’s found only in the vulva. The main treatment for this cancer is surgery. Share ...

Regeneron Pharmaceuticals has won expanded European approval of its blockbuster cancer drug Libtayo for certain patients with skin cancer. Regeneron on Wednesday said the European Commission's nod ...

It is best to seek treatment for cutaneous squamous cell carcinoma (cSCC) as early as possible, as doctors can usually treat early stage cSCC easily and locally. Delays in treatment could mean cancer ...

The U.S. Food and Drug Administration said on Wednesday that it has approved Bayer's drug for patients with a form of lung ...